Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2016-05-27

Clinical Trial Update: Omega-3 and Blueberry Supplementation in Age-Related Cognitive Decline [NA]

View source ↗

Summary

This completed clinical trial evaluated omega-3 fatty acids and blueberry supplementation for age-related memory and mood disorders.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Blueberry supplementation
  • Omega-3 fatty acids (omega-3 fatty acids)

Snippet

Sponsor: University of Cincinnati | Conditions: Age-related Memory Disorders, Mood Disorders | NA | Status: COMPLETED